NCT05978973
Elemental Diet and Gut Microbiome
Cedars-Sinai Medical Center·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Irritable Bowel Syndrome
- Drug/Device/Intervention
- Elemental Diet
- Study type
- Interventional
- Intervention type
- dietary supplement
Sponsor & location
- Primary sponsor
- Cedars-Sinai Medical Center
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 01, 2023
- End date
- Jun 01, 2025
- Enrollment
- 30 participants
Primary outcome
assess changes in stool microbiome profiles
Summary
he primary objective of this study is to assess changes in stool microbiome profiles in
 patients after an elemental diet.
ICD-10 classifications
Irritable bowel syndromeOther and unspecified irritable bowel syndromeIrritable bowel syndrome with mixed bowel habits [IBS-M]Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndrome with predominant diarrhoea [IBS-D]
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05978973
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT05978973 through Pure Global AI's free database. This phase not specified trial is sponsored by Cedars-Sinai Medical Center and is currently Not yet recruiting. The study focuses on Irritable Bowel Syndrome. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.